0001209191-21-062548.txt : 20211102 0001209191-21-062548.hdr.sgml : 20211102 20211102201939 ACCESSION NUMBER: 0001209191-21-062548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211025 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schadt Eric CENTRAL INDEX KEY: 0001873468 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39482 FILM NUMBER: 211373262 MAIL ADDRESS: STREET 1: C/O SEMA4 HOLDINGS CORP STREET 2: 333 LUDLOW STREET, NORTH TOWER, 8TH FL. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sema4 Holdings Corp. CENTRAL INDEX KEY: 0001818331 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 851966622 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LUDLOW STREET STREET 2: NORTH TOWER, 8TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 617 780 8742 MAIL ADDRESS: STREET 1: 333 LUDLOW STREET STREET 2: NORTH TOWER, 8TH FLOOR CITY: STAMFORD STATE: CT ZIP: 06902 FORMER COMPANY: FORMER CONFORMED NAME: CM Life Sciences, Inc. DATE OF NAME CHANGE: 20200715 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-25 0 0001818331 Sema4 Holdings Corp. SMFR 0001873468 Schadt Eric C/O SEMA4 HOLDINGS CORP. 333 LUDLOW ST, NORTH TOWER, 8TH FL. STAMFORD CT 06902 1 1 0 0 Chief Executive Officer Class A Common Stock 2021-10-25 4 M 0 78812 A 78812 D Class A Common Stock 2021-10-25 4 S 0 33332 7.54 D 45480 D Restricted Stock Unit 2021-10-25 4 M 0 78812 0.00 D Class A Common Stock 78812 1182187 D Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. /s/ Daniel Clark, Attorney-in-Fact 2021-11-02